These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23826539)

  • 1. Nanoparticles in the ocular drug delivery.
    Zhou HY; Hao JL; Wang S; Zheng Y; Zhang WS
    Int J Ophthalmol; 2013; 6(3):390-6. PubMed ID: 23826539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular drug delivery.
    Gaudana R; Ananthula HK; Parenky A; Mitra AK
    AAPS J; 2010 Sep; 12(3):348-60. PubMed ID: 20437123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.
    Akhter MH; Ahmad I; Alshahrani MY; Al-Harbi AI; Khalilullah H; Afzal O; Altamimi ASA; Najib Ullah SNM; Ojha A; Karim S
    Gels; 2022 Jan; 8(2):. PubMed ID: 35200463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.
    Singh RB; Ichhpujani P; Thakur S; Jindal S
    Ther Adv Ophthalmol; 2020; 12():2515841420905740. PubMed ID: 32206746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases.
    Su Y; Fan X; Pang Y
    Biomater Sci; 2023 Jun; 11(13):4490-4507. PubMed ID: 37222479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Drug Delivery.
    Yavuz B; Kompella UB
    Handb Exp Pharmacol; 2017; 242():57-93. PubMed ID: 27783270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
    Amrite AC; Edelhauser HF; Singh SR; Kompella UB
    Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
    Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye.
    Tsai CH; Hoang LN; Lin CC; Pan LC; Wu CL; Lin IC; Wang PY; Tseng CL
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
    Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
    Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of therapeutics for deep-seated ocular conditions - status quo.
    Nguyen H; Eng S; Ngo T; Dass CR
    J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Rupenthal ID
    Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of nanoparticles in ophthalmology.
    Diebold Y; Calonge M
    Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye.
    Wang Y; Zhou L; Fang L; Cao F
    Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection.
    Huang D; Chen YS; Thakur SS; Rupenthal ID
    Eur J Pharm Biopharm; 2017 Oct; 119():125-136. PubMed ID: 28602870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
    Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
    AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes and nanotechnology in drug development: focus on ocular targets.
    Honda M; Asai T; Oku N; Araki Y; Tanaka M; Ebihara N
    Int J Nanomedicine; 2013; 8():495-503. PubMed ID: 23439842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
    Cholkar K; Patel A; Vadlapudi AD; Mitra AK
    Recent Pat Nanomed; 2012; 2(2):82-95. PubMed ID: 25400717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.